Need immediate assistance? Call 1-518-730-0559 (Us-Canada Toll Free) or Contact Us

 

Red Biotechnology Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019 – 2027

Table of Content

    1. Global Red Biotechnology Market – Preface
        1.1. Market Definition and Scope
        1.2. Market Segmentation
        1.3. Key Research Objectives
        1.4. Research Highlights
    2. Assumptions and Research Methodology
        2.1. Red Biotechnology Market Definition
        2.2. Red Biotechnology Market Taxonomy
    3. Executive Summary : Global Red Biotechnology Market
Market Overview

        3.1. Introduction
            3.1.1. Definition
            3.1.2. Industry Evolution / Developments
        3.2. Overview
        3.3. Market Dynamics
            3.3.1. Drivers
            3.3.2. Restrains
            3.3.3. Opportunities
        3.4. Global Red Biotechnology Market Analysis and Forecast, 2017–2027
        3.5. Market Revenue Projections (US$ Bn)
    4. Market Outlook
        4.1. Pipeline Analysis
        4.2. Mergers & Acquisitions
    5. Global Red Biotechnology Market Analysis and Forecast, by Application 
        5.1. Introduction
        5.2. Key Findings / Developments, by Type 
        5.3. Global Red Biotechnology Market Value (US$ Bn) Forecast, by Application, 2017?2027
            5.3.1. Biopharmaceutical Production
            5.3.2. Gene Therapy
            5.3.3. Pharmacogenomics
            5.3.4. Genetic Testing
        5.4. Global Red Biotechnology Market Attractiveness Analysis, by Application 
    6. Global Red Biotechnology Market Analysis and Forecast, by End-user 
        6.1. Introduction
        6.2. Key Findings / Developments, by End-user 
        6.3. Global Red Biotechnology Market Value (US$ Bn) Forecast, by End-user, 2017?2027
            6.3.1. Pharmaceutical Industry 
            6.3.2. CMO & CRO
            6.3.3. Research Institutes
            6.3.4. Others 
        6.4. Global Red Biotechnology Market Attractiveness Analysis, by End-user
    7. Global Red Biotechnology Market Analysis and Forecast, by Region/sub-Region
        7.1. Key Findings / Developments 
        7.2. Global Red Biotechnology Market Value (US$ Bn) Forecast, by Region/Sub-Region, 2017?2027
            7.2.1. North America
            7.2.2. Europe
            7.2.3. Asia Pacific 
            7.2.4. Latin America
            7.2.5. Middle East and Africa (MEA)
        7.3. Global Red Biotechnology Market Attractiveness Analysis, by Region/Sub-Region
    8. North America Red Biotechnology Market Analysis and Forecast
        8.1. Introduction
            8.1.1. Key Findings / Developments 
        8.2. North America Red Biotechnology Market Value (US$ Bn) Forecast, by Country, 2017?2027
            8.2.1. U.S.
            8.2.2. Canada
        8.3. North America Red Biotechnology Market Value (US$ Bn) Forecast, by Application, 2017?2027
            8.3.1. Biopharmaceutical Production
            8.3.2. Gene Therapy
            8.3.3. Pharmacogenomics
            8.3.4. Genetic Testing
        8.4. North America Red Biotechnology Market Value (US$ Bn) Forecast, by End-user, 2017?2027
            8.4.1. Pharmaceutical Industry 
            8.4.2. CMO & CRO
            8.4.3. Research Institutes
            8.4.4. Others 
        8.5. North America Red Biotechnology Market Attractiveness Analysis
            8.5.1. By Country
            8.5.2. By Application 
            8.5.3. By End-user 
    9. Europe Red Biotechnology Market Analysis and Forecast
        9.1. Introduction
            9.1.1. Key Findings / Developments 
        9.2. Europe Red Biotechnology Market Value (US$ Bn) and Forecast, by Country /Sub-Region, 2017?2027
            9.2.1. Germany
            9.2.2. France
            9.2.3. Italy
            9.2.4. Spain
            9.2.5. U.K.
            9.2.6. Rest of  Europe
        9.3. Europe Red Biotechnology Market Value (US$ Bn) Forecast, by Application, 2017?2027
            9.3.1. Biopharmaceutical Production
            9.3.2. Gene Therapy
            9.3.3. Pharmacogenomics
            9.3.4. Genetic Testing
        9.4. Europe Red Biotechnology Market Value (US$ Bn) Forecast, by End-user, 2017?2027
            9.4.1. Pharmaceutical Industry 
            9.4.2. CMO & CRO
            9.4.3. Research Institutes
            9.4.4. Others 
        9.5. Europe Red Biotechnology Market Attractiveness Analysis
            9.5.1. By Country/Sub-region
            9.5.2. By Application 
            9.5.3. By End-user 
    10. Asia Pacific  Red Biotechnology Market Analysis and Forecast
        10.1. Introduction
            10.1.1. Key Findings / Developments 
        10.2. Asia Pacific Red Biotechnology Market Value (US$ Bn) and Forecast, by Country / Region, 2017?2027
            10.2.1. China
            10.2.2. India
            10.2.3. Japan
            10.2.4. Australia and New Zealand
            10.2.5. Rest of Asia-Pacific
        10.3. Asia Pacific Red Biotechnology Market Value (US$ Bn) Forecast, by Application, 2017?2027
            10.3.1. Biopharmaceutical Production
            10.3.2. Gene Therapy
            10.3.3. Pharmacogenomics
            10.3.4. Genetic Testing
        10.4. Asia Pacific Red Biotechnology Market Value (US$ Bn) Forecast, by End-user, 2017?2027
            10.4.1. Pharmaceutical Industry 
            10.4.2. CMO & CRO
            10.4.3. Research Institutes
            10.4.4. Others 
        10.5. Asia Pacific Red Biotechnology Market Attractiveness Analysis
            10.5.1. By Country/Sub-region
            10.5.2. By Application 
            10.5.3. By End-user 
    11. Latin America Red Biotechnology Market Analysis and Forecast
        11.1. Introduction
            11.1.1. Key Findings / Developments 
        11.2. Latin America Red Biotechnology Market Value (US$ Bn) and Forecast, by Country, 2017?2027
            11.2.1. Brazil
            11.2.2. Mexico
            11.2.3. Rest of Latin America
        11.3. Latin America Red Biotechnology Market Value (US$ Bn) Forecast, by Application, 2017?2027
            11.3.1. Biopharmaceutical Production
            11.3.2. Gene Therapy
            11.3.3. Pharmacogenomics
            11.3.4. Genetic Testing
        11.4. Latin America Red Biotechnology Market Value (US$ Bn) Forecast, by End-user, 2017?2027
            11.4.1. Pharmaceutical Industry 
            11.4.2. CMO & CRO
            11.4.3. Research Institutes
            11.4.4. Others 
        11.5. Latin America Red Biotechnology Market Attractiveness Analysis
            11.5.1. By Country/Sub-region
            11.5.2. By Application 
            11.5.3. By End-user 
    12. Middle East & Africa Red Biotechnology Market Analysis and Forecast
        12.1. Introduction
            12.1.1. Key Findings / Developments 
        12.2. Middle East & Africa Red Biotechnology Market Value (US$ Bn) Forecast, by Country, 2017?2027
            12.2.1. GCC Countries
            12.2.2. South Africa
            12.2.3. Rest of MEA
        12.3. Middle East & Africa Red Biotechnology Market Value (US$ Bn) Forecast, by Application, 2017?2027
            12.3.1. Biopharmaceutical Production
            12.3.2. Gene Therapy
            12.3.3. Pharmacogenomics
            12.3.4. Genetic Testing
        12.4. Middle East & Africa Red Biotechnology Market Value (US$ Bn) Forecast, by End-user, 2017?2027
            12.4.1. Pharmaceutical Industry 
            12.4.2. CMO & CRO
            12.4.3. Research Institutes
            12.4.4. Others 
        12.5. Middle East & Africa Red Biotechnology Market Attractiveness Analysis
            12.5.1. By Country/Sub-region
            12.5.2. By Application 
            12.5.3. By End-user 
    13. Competition Landscape
        13.1. Market Player – Competition Matrix 
        13.2. Market Share Analysis, by Company (2018)
        13.3. Company Profiles
            13.3.1. Pfizer, Inc.
            13.3.2. Biogen Inc.
            13.3.3. Amgen Inc.
            13.3.4. AstraZeneca Plc.
            13.3.5. Gilead Sciences, Inc.
            13.3.6. CELGENE CORPORATION
            13.3.7. F. Hoffmann-La Roche, Ltd.
            13.3.8. Merck KGaA
            13.3.9. Regeneron Pharmaceuticals, Inc.
            13.3.10.  Takeda Pharmaceutical Company Limited 

Custom Market Research Services

MRRSE offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Get A Free Custom Research Quote